Evidence map›Paper›PMID 39037009›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2024

The repertoire of iron superoxide dismutases from

Juan Carlos García-Soriano, Héctor de Lucio, Daniel Elvira-Blázquez, Mercedes Alcón-Calderón, Natalia Sanz Del Olmo, Pedro A Sánchez-Murcia, Paula Ortega, Francisco Javier de la Mata, Antonio Jiménez-Ruiz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Juan Carlos García-SorianoDepartamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Spain.
Héctor de LucioDepartamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Spain.
Daniel Elvira-BlázquezDepartamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Spain.
Mercedes Alcón-CalderónDepartamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Spain.
Natalia Sanz Del OlmoDepartamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, Instituto de Química Andrés Manuel del Río, Alcalá de Henares, Spain.
Pedro A Sánchez-MurciaDivision of Medicinal Chemistry, Laboratory of Computer-Aided Molecular Design, Otto-Loewi Research Center, Medical University of Graz, Graz, Austria.
Paula OrtegaDepartamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, Instituto de Química Andrés Manuel del Río, Alcalá de Henares, Spain.
Francisco Javier de la MataDepartamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, Instituto de Química Andrés Manuel del Río, Alcalá de Henares, Spain.
Antonio Jiménez-RuizDepartamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Species of

Indexed as

Antiprotozoal AgentsDose-Response Relationship, DrugLeishmania infantumParasitic Sensitivity TestsSuperoxide DismutaseEnzyme InhibitorsLeishmaniasisMolecular StructureStructure-Activity RelationshipAntiprotozoal AgentsEnzyme InhibitorsSuperoxide Dismutasecytochrome c reduction assayLeishmaniametallodendrimerrutheniumSuperoxide dismutase

Identifiers

PMID39037009
PMCPMC11571740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.